(Q40426894)

English

Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen

scientific article

Statements

Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen (English)
Philippe Rouanet
Gustavo Linares-Cruz
François Dravet
Joelle Simony-Lafontaine
Elisabeth Le Nestour
Thierry Maudelonde

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit